Retraction Note to: LATS2 overexpression attenuates the therapeutic resistance of liver cancer HepG2 cells to sorafenib‐mediated death via inhibiting the AMPK–Mfn2 signaling pathway. This evidence concerns the gene LATS2 and liver cancer.